No Result
View All Result
  • Login
Tuesday, December 16, 2025
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Business

Adaptogens are popular for reducing stress and anxiety. One expert warns of the risks

by FeeOnlyNews.com
7 months ago
in Business
Reading Time: 3 mins read
A A
0
Adaptogens are popular for reducing stress and anxiety. One expert warns of the risks
Share on FacebookShare on TwitterShare on LInkedIn



Finding a way to manage stress and anxiety takes a lot of mental effort, which is why some look to supplements for additional support. And if you’ve ever researched the many different suggestions for stress and anxiety management, you’ve likely come across the term adaptogens. These are ingredients derived from herbs, roots, mushrooms, and plants that are converted into nutritional supplements or added to other foods.

Adaptogen supplements have surged in popularity—the market value was estimated at over $10 billion in 2023 and only expected to grow. Common adaptogen supplements include ashwagandha, rhodiola, and ginseng, which can be found in capsules or teas; and fungi, like the reishi mushroom, which is often dried and crushed into a powder. As adaptogens have become more mainstream, you can even buy in the form of mushroom coffee, sparkling water, and drink mixes.

But do these supplements actually work? Here’s what one expert has to say.

Do adaptogens help relieve stress and anxiety?

Adaptogens “may help our bodies manage stress or more-quickly restore homeostasis (or the body’s natural balance) after stressful situations,” says Dana Hunnes, senior dietitian supervisor at UCLA Medical Center and professor at the Fielding School of Public Health. 

Those stressors can be physiological, like an injury or burnout from work, or psychological, such as from emotional distress, she adds.

Hunnes explains that adaptogens may help lower cortisol levels which would dampen the body’s stress response. But that largely depends on the dose you get, which can be hard to pinpoint.

“It’s not really clear how effective they are and what dose is ‘needed’ to have the desired effect,” Hunnes tells Fortune in an email. 

Ashwagandha, for example, is an herb that’s been used for centuries in India’s Ayurvedic system of medicine. Some research indicates that it may help improve sleep and alleviate anxiety. But how much is needed to benefit is unclear.

“Additionally, it’s not known whether the dose of adaptogens that are available for purchase, or the amounts found in supplements or beverages on the market are high enough to produce a medicinal effect,” Hunnes says.

And since there is little evidence that one type of adaptogen is better than another, Hunnes explains, so it’s hard to say which will work best for you. 

The risks of taking adaptogens

Adaptogens, like other supplements, aren’t regulated the way drugs are—which could lead to a wide variation in dosage. “So what you think you’re buying may not actually contain as much—or may sometimes contain more—than you think,” Hunnes says.

She also cautions that adaptogens carry risks and side effects, which is why you should always talk to your doctor before taking any supplement. Ashwagandha, one of the more popular forms of adaptogens, has been associated with an increased risk of acute liver toxicity or shock and should not be used during pregnancy. Ashwagandha may also increase testosterone levels, which is often not desirable for women.  

Reishi mushroom may produce side effects, like nausea and insomnia, and could cause liver damage, according to Memorial Sloan Kettering Cancer Center.

“Not every ‘herbal supplement’ is good for you or safe to consume,” Hunnes says.

Additionally, there are potential drug interactions that come with any adaptogens, she says. Reishi mushroom could negatively interact with commonly prescribed blood thinners, like warfarin, increasing the risk of bleeding. Taking adaptogens with antidepressants could lead to symptoms like abdominal pain, nausea, and restless leg syndrome. 

“Just because something claims to be healthy in isolation, does not mean it will be healthy in your body or mixed with other medications,” Hunnes says.

Should you take adaptogens?

“I honestly wouldn’t recommend it,” Hunnes says. “There are just too many unknown or unknowable interactions that can take place between taking ‘supplements’ and ‘herbs’ and medications, even over the counter medications.”

“I really would advocate for finding non-medicinal ways of dealing with anxiety or stress,” she adds.

If you find yourself in a period of high stress or anxiety, Hunnes recommends the following strategies before reaching for a supplement:

Slow down and take time for yourself.

Set boundaries.

Do things that relax you.

Spend time in nature.

Cut back on caffeine, which can cause more stimulation.

The American Psychological Association (APA) also has grounding and relaxation techniques to help calm your nervous system. However, if you are struggling with chronic stress and anxiety, the APA advises seeking professional help from a psychologist.

For more on supplements:

Why probiotic supplements might be ‘a waste of money’ and could even backfire for some

The dietary supplements you think are improving your health may be damaging your liver, research warns

The best diet to help lower your risk of prostate cancer, according to experts 

3 takeaways from a cardiologist and ‘SuperAgers’ researcher on how to live longer and healthier 

This story was originally featured on Fortune.com



Source link

Tags: AdaptogensAnxietyExpertPopularReducingRisksstressWarns
ShareTweetShare
Previous Post

Credit default swaps are in demand again amid U.S. fiscal worries

Next Post

Markets shrug off US appeals court’s decision to reinstate Trump tariffs

Related Posts

Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down .5 billion

Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down $19.5 billion

by FeeOnlyNews.com
December 16, 2025
0

Several months ago, Ford CEO Jim Farley said ending the nearly two-decade-long EV tax credit would halve America’s electric vehicle...

Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal

Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal

by FeeOnlyNews.com
December 16, 2025
0

Ace investors Vijay Kedia bought nearly 9 lakh shares in SME stock Mahamaya Lifesciences via a block deal on Tuesday....

Trump has ‘an alcoholic’s personality, chief of staff says in wide-ranging Vanity Fair interview. She calls it a ‘hit piece’

Trump has ‘an alcoholic’s personality, chief of staff says in wide-ranging Vanity Fair interview. She calls it a ‘hit piece’

by FeeOnlyNews.com
December 16, 2025
0

Susie Wiles, President Donald Trump’s understated but influential chief of staff, criticized Attorney General Pam Bondi’s handling of the Jeffrey...

Nvidia to pay NIS 90m for Kiryat Tivon site

Nvidia to pay NIS 90m for Kiryat Tivon site

by FeeOnlyNews.com
December 16, 2025
0

The deal under which Nvidia will construct a research and development campus at Kiryat Tivon (fifteen kilometers south-east of...

Is Solana Dying? DEX Trading Volume Drops 95% as SOL Price Continues to Fall

Is Solana Dying? DEX Trading Volume Drops 95% as SOL Price Continues to Fall

by FeeOnlyNews.com
December 16, 2025
0

Key Takeaways Participation on Solana-based decentralized exchanges has fallen significantly. Despite declining on-chain activity, Solana continues to attract investment and...

Next Vision wins biggest ever order

Next Vision wins biggest ever order

by FeeOnlyNews.com
December 16, 2025
0

Israeli stabilized camera company Next Vision Stabilized Systems (TASE: NXSN) has announced its largest ever order. The order, for...

Next Post
Markets shrug off US appeals court’s decision to reinstate Trump tariffs

Markets shrug off US appeals court's decision to reinstate Trump tariffs

IndusInd Bank: Sebi bans former IndusInd executives over insider trading allegations

IndusInd Bank: Sebi bans former IndusInd executives over insider trading allegations

  • Trending
  • Comments
  • Latest
Newsom, DeSantis join forces to blast ‘idiotic’ push to allow oil drilling off coasts of California, Florida

Newsom, DeSantis join forces to blast ‘idiotic’ push to allow oil drilling off coasts of California, Florida

November 23, 2025
Israeli housing rental platform Venn raises m

Israeli housing rental platform Venn raises $52m

November 18, 2025
What is a credit card spending limit — and what to know

What is a credit card spending limit — and what to know

August 4, 2025
Links 12/10/2025 | naked capitalism

Links 12/10/2025 | naked capitalism

December 10, 2025
5 Senior Discounts Being Eliminated by National Retailers

5 Senior Discounts Being Eliminated by National Retailers

December 7, 2025
AT&T promised the government it won’t pursue DEI

AT&T promised the government it won’t pursue DEI

December 4, 2025
Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down .5 billion

Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down $19.5 billion

0
ExxonMobil updates corporate plan; raises earnings, cash flow outlook

ExxonMobil updates corporate plan; raises earnings, cash flow outlook

0
Stocks making the biggest moves midday: LUV, CRCL, HAL

Stocks making the biggest moves midday: LUV, CRCL, HAL

0
16 Early-Morning Jobs for People Who Wake up With the Sun

16 Early-Morning Jobs for People Who Wake up With the Sun

0
US Homeland Security Rescues 62,000 Unaccompanied Minors From Trafficking

US Homeland Security Rescues 62,000 Unaccompanied Minors From Trafficking

0
Solana’s seamless operation post-DDoS signals a new era

Solana’s seamless operation post-DDoS signals a new era

0
Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down .5 billion

Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down $19.5 billion

December 16, 2025
Stocks making the biggest moves midday: LUV, CRCL, HAL

Stocks making the biggest moves midday: LUV, CRCL, HAL

December 16, 2025
16 Early-Morning Jobs for People Who Wake up With the Sun

16 Early-Morning Jobs for People Who Wake up With the Sun

December 16, 2025
Solana’s seamless operation post-DDoS signals a new era

Solana’s seamless operation post-DDoS signals a new era

December 16, 2025
8 Websites Where You Can Find Quality (and Affordable) Prescription Glasses

8 Websites Where You Can Find Quality (and Affordable) Prescription Glasses

December 16, 2025
8 things that happen when you finally stop matching energy with people who don’t deserve it

8 things that happen when you finally stop matching energy with people who don’t deserve it

December 16, 2025
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Ford’s CEO said the EV market would be halved without subsidies. Now he’s writing down $19.5 billion
  • Stocks making the biggest moves midday: LUV, CRCL, HAL
  • 16 Early-Morning Jobs for People Who Wake up With the Sun
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.